Resistance rates to clarithromycin, metronidazole, levofloxacin and amoxicillin among H. pylori clinical isolates from this study were 41%, 68%, 35% and 8% respectively, which are consistent with data ...

This came after the drug maker Abbott presented the justification for the Phase III clinical trial waiver along with the ...